SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-215626
Filing Date
2020-08-11
Accepted
2020-08-11 07:30:54
Documents
12
Period of Report
2020-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d65032d8k.htm   iXBRL 8-K 26694
  Complete submission text file 0001193125-20-215626.txt   153321

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrca-20200807.xsd EX-101.SCH 3066
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20200807_lab.xml EX-101.LAB 18887
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20200807_pre.xml EX-101.PRE 11857
5 EXTRACTED XBRL INSTANCE DOCUMENT d65032d8k_htm.xml XML 3456
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 201091058
SIC: 2834 Pharmaceutical Preparations